Exchange: NASDAQ·Updated 11:34 PM EST
IVVD logo

IVVD Invivyd Inc

$0.5588
$0.0211
(3.92%)
Overnight
Prev Close $0.5377
Reported EarningsNov 16
Mkt Cap$171.58M
Vol3.32M

About IVVD

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers ADG20, a monoclonal antibody, targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in New Haven, CT.
71

Bullish Sentiment

How do you feel about IVVD?

Ksa966
$IVVD 🤞 after 11 months of waiting I hope this go rocket Because I buy this at 3$ then I reduce until 1.71 So really hope this go back to 3 at least after the good news
10
MrTicker
$IVVD volume picking up... possible upside breakout.. $SLS i think we'll see a red to green move to close out the week. Imagine a positive readout early pre-market trading and the share price is up a few hundred %. very realistic. Happy Friday!
1
13
FriendlyGuy
$IVVD we are not hearing anything from management because they going through a sudden M&A, getting ACQUIRED!!! $SLS
16
PLX_BULLS
$IVVD if Merck or Pfizer would integrate IVDDs platform into their existing vaccinations… they could dramatically improve efficacy and tolerance without the need for all the preclinical and discovery. Shaving off billions in costs and years off development. Then they basically improved and relabeled a many decades old vaccination that gets a fresh code to a higher reimbursement price.
1
7
JustInTheMarket
$IVVD absolutely crushed Q3 earnings this morning! They beat across the board, bringing in $15.4M in PEMGARDA sales (up 18% YoY and easily topping the $15.04M consensus) while delivering a strong EPS beat at -$0.10 vs the -$0.13 expected. Even better, they are sitting on a massive $126.4M cash runway to fund everything without any immediate dilution worries. We have all been wondering where the VYD2311 DECLARATION data is, I wouldn't sweat it, management confirmed it’s coming "imminently." While I assumed they would bundle it, smart biotechs sometimes hold major Phase 3 readouts for a standalone press release so the news gets its own spotlight and doesn't get buried in earnings noise. With strong commercial execution already proven and the biggest catalyst right around the corner, we should see that data drop any day now or over the next couple of weeks. Huge setup heading into the end of the year! 📈 BULLISH
7
MrTicker
$IVVD measle cases are on the rise and the share price is starting to trend green with a bump in volume.. early indicator for a possible breakout https://www.reuters.com/legal/litigation/us-measles-cases-rise-5182-cdc-says-2026-11-06/ $SLS red to green move as i mentioned earlier.. as long as all major market index's stay green i think we could see a push above $8.50
1
7
billsmall
$IVVD As I run out the door qtr over qtr they burned about $33.7 mil (So they could scrape a yr if need be) and sales grew 8%. Better than a kick in the teeth. I'll have to catch the replay. GLA
6
FriendlyGuy
$IVVD They are waiting for the FDA, so they can drop the declaration data and FDA guidance at the same time in 1 PR. fair enough.
5
ImTiredofYourGarb
$IVVD it took them zero effort to get to the 52.. 52 week low. Same goes for back to the high. They own all of it.
5
M105
$IVVD Been looking for the bad news, all I see are facts that point to some serious move here in the near term
5
New_World_Man
$IVVD My 2 cents: I don’t believe that this delay in the Declaration results and BLA submission is due to anything bad. As they say, a titer is a titer is a titer. And the VYD2311 titers have already been shown to be exceptionally high in previous findings. I think the delay could possibly be due to deals being ironed out, funding, or even new and rapid event accumulation that has put them over the top to confidently fully unblind the trial. Time will tell.
7
PLX_BULLS
$IVVD if the trial was a dud… we would’ve seen a Friday after hours release. I’m moving my odds up to 80% approval and 60% AA approval.
6
JustInTheMarket
$IVVD I'm expecting heavy volume into the close and AH today ahead of a big morning tomorrow.
7
billsmall
$IVVD You really have to question the integrity of any leadership team that fails to communicate openly.
7
Rynr
$IVVD ~2.5-fold increase in neutralizing antibodies in the combination group compared to the vaccine alone, plus a long half-life, and another pathway the company is pursuing through the SPEAR STUDY to remove the spike protein that causes LONG COVID. Could this create a potential acquisition scenario by vaccine manufacturers if we get strong efficacy data?? 🤔
4
billsmall
$IVVD w/o news this will drift back. What little retail there is they are frustrated in the lack of transparency. (And we should be)
6
PLX_BULLS
$IVVD what wetsalmon posted a few weeks… help bring me in. I can see the global giants like Merck or Pfizer wanting a piece of IVVDs platform for their collage of vaccinations.
5
FriendlyGuy
$IVVD Point72 is a major hedge fund run by Steven Cohen. They were a major stake holder in IVVD. The stock ran all the way from $0,60 to $2,50 where they sold all of their shares. In recent F13 filings we saw that Point72 bought back all of their original amount of shares around $1.30!!
5
SHVR89
$IVVD Nothing new, nothing worse. In my view the catalyst is data + FDA alignment together, not data alone. Year-end tax-loss selling could add pressure until then. I'm holding and watching
3
MrTicker
$IVVD $SLS almost hit my $8.50 target on SLS. Possibly after hours. Ill take it. Keep an eye on $PRFX after hours..low volume uptrend and has ran a few times after hours.
5

Advertisement|Remove ads.